Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Cash from Investing Activities: 2010-2019

Historic Cash from Investing Activities for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $101,000.

  • EyePoint Pharmaceuticals' Cash from Investing Activities fell 99.40% to $101,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $16.6 million, marking a year-over-year increase of 209.25%. This contributed to the annual value of -$219.4 million for FY2024, which is 6517.04% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Cash from Investing Activities stood at $101,000 for Q4 2019, which was up 155.49% from -$182,000 recorded in Q1 2019.
  • Over the past 5 years, EyePoint Pharmaceuticals' Cash from Investing Activities peaked at $16.8 million during Q4 2018, and registered a low of -$16.8 million during Q2 2018.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$64,000 (2017), whereas its average is -$1.1 million.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Cash from Investing Activities slumped by 7,700.00% in 2015, and later spiked by 8,628.57% in 2016.
  • Over the past 5 years, EyePoint Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at -$28,000 in 2015, then surged by 8,628.57% to $2.4 million in 2016, then crashed by 101.17% to -$64,000 in 2017, then crashed by 70.31% to $16.8 million in 2018, then plummeted by 99.40% to $101,000 in 2019.
  • Its Cash from Investing Activities was $101,000 in Q4 2019, compared to -$182,000 in Q1 2019 and $16.8 million in Q4 2018.